EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mogroside V: A Review of Its Structure, Synthesis, Pharmacokinetics, and Toxicity

Tengyue Zhang, Zhijie Gao, Dexian Zeng, Yanhua Wang iD

Archiv der Pharmazie · 2025-10 · 358 (10)

DOI: 10.1002/ardp.70112 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, online erschienen am 05.10.2025. Verfasst von Tengyue Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical Science, China Three Gorges University, Yichang, China. Hauptthemen laut MEDLINE: Triterpenes, Neuroprotective Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: This study was supported by National Natural Science Foundation of China (grant no. 81602559)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mogroside V (MOG‐V), a natural triterpene glycoside predominantly derived from the fruit pulp of Siraitia grosvenorii , is widely recognized as a high‐intensity non‐caloric sweetener. In recent years, it has attracted considerable research interest due to its broad pharmacological activities, including anti‐inflammatory, antioxidant, anticancer, and neuroprotective effects. Notably, MOG‐V exhibits a remarkable capacity to scavenge intracellular reactive oxygen species (ROS), thereby supporting mitochondrial function and promoting cellular homeostasis. It has also shown promising efficacy in alleviating pneumonia. Mechanistic studies indicate that MOG‐V modulates glucose and lipid metabolism through activation of the AMPK signaling pathway. Furthermore, it confers neuroprotective benefits in models of Parkinson's disease via regulation of critical metabolic pathways. Despite these advances, a comprehensive and critical outlook on the synthesis, pharmacological mechanisms, and therapeutic applications of MOG‐V remains lacking. Based on the current research status and existing limitations, this review provides a comprehensive analysis of MOG‐V, including its structural characteristics, novel synthetic approaches, and pharmacological investigations. Furthermore, it critically evaluates the therapeutic potential of MOG‐V and identifies promising directions for future research. This study systematically consolidates and assesses the available knowledge of MOG‐V, with the aim of clarifying its mechanistic foundations and proposing novel insights for subsequent studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriterpenesNeuroprotective AgentsHumansAnimalsMolecular StructureStructure-Activity RelationshipAnti-Inflammatory Agents

Stichwörter der Autor:innen

disease therapyfood efficacymogroside Vpharmacologyplant therapy

Substanzen

Triterpenesmogroside VNeuroprotective AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • College of Basic Medical Science, China Three Gorges University, Yichang, China.
  • Tianjia Bing College of education, China Three Gorges University, Yichang, China.
  • The Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, China.

ORCID-Profile: Yanhua Wang

Förderung

  • This study was supported by National Natural Science Foundation of China (grant no. 81602559).

Zitieren

APA

Zhang, T., Gao, Z., Zeng, D., & Wang, Y. (2025). Mogroside V: A Review of Its Structure, Synthesis, Pharmacokinetics, and Toxicity. Archiv der Pharmazie, 358(10). https://doi.org/10.1002/ardp.70112

Vancouver

Zhang T, Gao Z, Zeng D, Wang Y. Mogroside V: A Review of Its Structure, Synthesis, Pharmacokinetics, and Toxicity. Archiv der Pharmazie. 2025;358(10). doi:10.1002/ardp.70112

BibTeX
@article{Zhang2025,
  author = {Zhang, Tengyue and Gao, Zhijie and Zeng, Dexian and Wang, Yanhua},
  title = {Mogroside V: A Review of Its Structure, Synthesis, Pharmacokinetics, and Toxicity},
  journal = {Archiv der Pharmazie},
  year = {2025},
  volume = {358},
  number = {10},
  doi = {10.1002/ardp.70112}
}
Kostenlos starten →